New conditioning regimen with idarubicin and melphalan in autologous PBPC transplantation

被引：0
|
作者：
Musso, M
Porretto, F
Crescimanno, A
Bondi, F
Polizzi, V
Scalone, R
Cajozzo, A
Mariani, G
机构：
[1] Univ Palermo, Cattedra Ematol TMO, I-90133 Palermo, Italy
[2] Univ Palermo, Div Ematol TMO, I-90133 Palermo, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
342
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [41] Autologous bone marrow transplantation for acute myeloid leukaemia in children using total body irradiation and melphalan as conditioning regimen
    Bonetti, F
    Locatelli, F
    Pession, A
    Messina, C
    Giorgiani, G
    Zecca, M
    Santoro, N
    Porta, F
    Favre, C
    Montagna, D
    BLOOD, 1995, 86 (10) : 356 - 356
  • [42] Four years survival in autologous stem cell transplantation with moderate dose of idarubicin and busulphan as conditioning regimen in acute myelogenous leukemia
    Mashhadi, M. A., Sr.
    Ramzi, M.
    Alimoghaddam, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] INTRAVENOUS BUSULPHAN IN COMBINATION WITH ETOPOSIDE AND MELPHALAN USED AS CONDITIONING REGIMEN FOR AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN LYMPHOMAS: EVALUATION OF TOXICITY
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Papalexandri, A.
    Penopoulos, V.
    Sakellari, I.
    Anagnostopoulos, A.
    Fassas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 449 - 450
  • [44] Mitoxantrone and melphalan as conditioning regimen for autologous stem cell transplant for multiple myeloma.
    Beaven, Anne W.
    Comeau, Terrance
    Sharf, Andrew
    Moore, Dominic T.
    Serody, Jonathan
    Shea, Thomas C.
    Gabriel, Don A.
    BLOOD, 2006, 108 (11) : 834A - 834A
  • [45] High-dose idarubicin (I) and melphalan (M) with total body irradiation (TBI) or busulfan (Bu) as conditioning for allogeneic and autologous transplantation (SCT).
    Juliusson, G
    Malm, C
    Karlsson, K
    BONE MARROW TRANSPLANTATION, 1999, 23 : S74 - S74
  • [46] BTM: an alternative conditioning regimen for autologous stem cell transplantation
    De Rosa, G.
    Morelli, E.
    Montante, B.
    De Rosa, A.
    Rotoli, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
  • [47] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
  • [48] Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience
    Martino, Massimo
    Messina, Giuseppe
    Moscato, Tiziana
    Fedele, Roberta
    Console, Giuseppe
    Console, Giuseppe
    Vincelli, Iolanda Donatella
    Ronco, Francesca
    Irrera, Giuseppe
    BLOOD, 2014, 124 (21)
  • [49] Effect of dose of melphalan used in conditioning regimen on outcomes of autologous stem cell transplantation in overweight/obese patients with multiple myeloma
    Ellent, Elizabeth
    Pai, Sachin Gopalkrishn
    Chasick, Ashley
    Luo, Qingyang
    Wendling, Charles V.
    Emmons, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
    Farnault, L.
    Venton, G.
    Pourroy, B.
    Jourde-Chiche, N.
    Ivanov, V.
    Arcani, R.
    Roche, P.
    Mercier, C.
    Colle, J.
    Fanciullino, R.
    Costello, R. T.
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1173 - 1175
12345